Trevi Therapeutics, Inc. (TRVI)
USD 4.15
(-7.78%)
USD 4.15
(-7.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -31.71 Million | -28.17 Million | -28.94 Million | -29 Million | -23.09 Million | -18.29 Million |
| Net Income | -29.06 Million | -29.15 Million | -33.94 Million | -32.75 Million | -26.05 Million | -20.54 Million |
| Depreciation & Amortization | 123 Thousand | 43 Thousand | 50 Thousand | 47 Thousand | 39 Thousand | 23 Thousand |
| Deferred income taxes | 1.04 Million | - | -82 Thousand | 9000.00 | - | - |
| Stock-based compensation | 2.24 Million | 2.32 Million | 2.54 Million | 2.41 Million | 1.12 Million | 496 Thousand |
| Change in working capital | -3.84 Million | -1.23 Million | 1.5 Million | 1.05 Million | 1.57 Million | -568 Thousand |
| Other non-cash items | -2.21 Million | -162 Thousand | 974 Thousand | 227 Thousand | 215 Thousand | 2.3 Million |
| Investing Cash Flow | 59.42 Million | -107.37 Million | - | -32 Thousand | -9000.00 | -158 Thousand |
| Investments in PPE | -137 Thousand | -159 Thousand | - | -32 Thousand | -9000.00 | -158 Thousand |
| Acquisitions | -2.12 Million | -829 Thousand | - | - | - | - |
| Investment purchases | -9.93 Million | -126.21 Million | - | - | - | - |
| Sales/Maturities of investments | 69.49 Million | 19 Million | - | - | - | - |
| Other Investing Activities | 2.12 Million | 829 Thousand | - | -32 Thousand | -9000.00 | - |
| Financing Cash Flow | -7910.00 | 111.3 Million | 20.77 Million | 16.72 Million | 73.21 Thousand | 3629.00 |
| Debt repayment | -9504.00 | -5.83 Million | -68 Thousand | -13.91 Million | - | -4813.00 |
| Dividends payments | - | - | - | - | -2.23 Million | - |
| Common Stock Repurchased | - | - | - | - | -1.21 Million | - |
| Common Stock Issuance | -116 Thousand | 105.41 Million | 21.18 Million | 3.13 Million | 73.88 Million | -1.52 Million |
| Other Financing Activities | 1594.00 | 11.73 Million | -340 Thousand | 27.5 Million | 73.21 Thousand | 8442.00 |
| Accounts receivables | - | - | - | 293 Thousand | -374 Thousand | -135 Thousand |
| Accounts payables | -1.04 Million | 9000.00 | 831 Thousand | 417 Thousand | 777 Thousand | 66 Thousand |
| Inventory | - | - | - | -293 Thousand | 374 Thousand | - |
| Other working capital | -2.79 Million | -1.24 Million | 678 Thousand | 641 Thousand | 799 Thousand | -634 Thousand |
| Cash at beginning of period | 12.58 Million | 36.83 Million | 45 Million | 57.31 Million | 7.2 Million | 22.02 Million |
| Cash at end of period | 32.39 Million | 12.58 Million | 36.83 Million | 45 Million | 57.31 Million | 7.2 Million |
| Capital Expenditure | -137 Thousand | -159 Thousand | - | -32 Thousand | -9000.00 | -158 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 19.8 Million | -24.24 Million | -8.17 Million | -12.31 Million | 50.11 Million | -14.81 Million |
| Free Cash Flow | -31.84 Million | -28.33 Million | -28.94 Million | -29.03 Million | -23.1 Million | -18.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.35 Million | -10.9 Million | -7.82 Million | -29.06 Million | -7.69 Million | -7.14 Million |
| Depreciation & Amortization | 38 Thousand | 35 Thousand | 35 Thousand | 123 Thousand | 35 Thousand | 34 Thousand |
| Deferred income taxes | - | - | 23 Thousand | 1.04 Million | -472 Thousand | -631 Thousand |
| Stock-based compensation | 1.12 Million | 723 Thousand | 534 Thousand | 2.24 Million | 530 Thousand | 605 Thousand |
| Change in working capital | 2.72 Million | -62 Thousand | 736 Thousand | -3.84 Million | 207 Thousand | -2.97 Million |
| Other non-cash items | 1.59 Million | 238 Thousand | 134 Thousand | -2.21 Million | 119 Thousand | 239 Thousand |
| Investing Cash Flow | 2.76 Million | -8.09 Million | 12.84 Million | 59.42 Million | 17.98 Million | 19.63 Million |
| Investments in PPE | -28 Thousand | - | -22 Thousand | -137 Thousand | -18 Thousand | -40 Thousand |
| Acquisitions | - | - | 671 Thousand | -2.12 Million | - | - |
| Investment purchases | -9.95 Million | -30.26 Million | -951 Thousand | -9.93 Million | - | - |
| Sales/Maturities of investments | 12.75 Million | 22.17 Million | 13.81 Million | 69.49 Million | 18 Million | 19.67 Million |
| Other Investing Activities | 2796.00 | 381 Thousand | 12.86 Thousand | 2.12 Million | 18 Thousand | 19.67 Thousand |
| Financing Cash Flow | 5.06 Million | -28 Thousand | -54.00 | -7910.00 | 1510.00 | -7663.00 |
| Debt repayment | -31 Thousand | -32 Thousand | -32.00 | -9504.00 | -31.00 | -7691.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 248 Thousand | 4000.00 | -1.73 Million | -116 Thousand | 1.54 Million | 28 Thousand |
| Other Financing Activities | 4.85 Million | 4000.00 | -22.00 | 1594.00 | 1541.00 | 28.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -618 Thousand | 294 Thousand | 627 Thousand | -1.04 Million | -170 Thousand | -592 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.34 Million | -356 Thousand | 109 Thousand | -2.79 Million | 377 Thousand | -2.38 Million |
| Cash at beginning of period | 13.81 Million | 32.39 Million | 25.96 Million | 12.58 Million | 13.75 Million | 11.65 Million |
| Cash at end of period | 12.96 Million | 13.81 Million | 32.39 Million | 32.39 Million | 25.96 Million | 13.75 Million |
| Capital Expenditure | -28 Thousand | - | -22 Thousand | -137 Thousand | -18 Thousand | -40 Thousand |
| Effect of forex changes on cash | - | - | 13.86 Million | - | -12 Million | -1.86 Million |
| Net cash flow / Change in cash | -848 Thousand | -18.58 Million | 6.43 Million | 19.8 Million | 12.21 Million | 2.1 Million |
| Free Cash Flow | -8.71 Million | -10.46 Million | -6.38 Million | -31.84 Million | -7.29 Million | -9.91 Million |
CRWD
HTIBP
PURSHOTTAM
003520
2441
BHAC